Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Breast Neoplasms 11Prostatic Neoplasms 10Glioblastoma 10Oropharyngeal Neoplasms 7Rectal Neoplasms 6Neoplasms 6Lung Neoplasms 6Astrocytoma 6Squamous Cell Carcinoma of Head and Neck 5Urinary Bladder Neoplasms 4Burkitt Lymphoma 4Adenocarcinoma of Lung 4Pancreatic Neoplasms 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Lymphoma, Follicular 3Hodgkin Disease 3Gliosarcoma 3Glioma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma 3Triple Negative Breast Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Neoplasm, Residual 2Mesothelioma, Malignant 2Meningeal Carcinomatosis 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

Specimen Handling 3pembrolizumab 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Biopsy 2talimogene laherparepvec 1peposertib 1liposomal doxorubicin 1fludarabine 1aldesleukin 1X-Rays 1Radiotherapy 1Radiation 1Nivolumab 1Ipilimumab 1Histamine H2 Antagonists 1Famotidine 1Cyclophosphamide 1CTLA-4 Antigen 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × Radiotherapy × 30 days × Clear all
NCT02923778 2026-05-13

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡